Comparison of dendritic cell-mediated immune responses among canine malignant cells

Journal of Veterinary Medical Science

Volumn 69, Issue 9, 2007, Pages 925-930

  Tamura, Kyoichi ^a   Arai, Hiroyoshi ^a   Ueno, Emi ^a   Saito, Chie ^a   Yagihara, Hiroko ^a   Isotani, Mayu ^a   Ono, Kenichiro ^b   Washizu, Tsukimi ^a   Bonkobara, Makoto ^a  

^a NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Canine; Delayed type hypersensitivity; Dendritic cell; Malignancies; Vaccination

Indexed keywords

CANIS FAMILIARIS;

CANCER VACCINE;

ADOPTIVE IMMUNOTHERAPY; ANIMAL; ANIMAL DISEASE; ARTICLE; B CELL LYMPHOMA; COMPARATIVE STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DOG; DOG DISEASE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METHODOLOGY; PATHOLOGY; SARCOMA; SKIN; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ANIMALS; CANCER VACCINES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DENDRITIC CELLS; DOG DISEASES; DOGS; FLOW CYTOMETRY; HYPERSENSITIVITY, DELAYED; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY, ADOPTIVE; LYMPHOMA, B-CELL; SARCOMA; SKIN;

EID: 35848935838     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.69.925     Document Type: Article

References (22)

1. Ackermann, B., Troger, A., Glouchkova, L., Korholz, D., Gobel, U. and Dilloo, D. 2004. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis. Klin. Padiatr. 216: 176-182.
2. Azakami, D., Bonkobara, M., Washizu, T., Iida, A., Kondo, M., Kato, R., Niikura, Y., Iwaki, S., Tamahara, S., Matsuki, N. and Ono, K. 2006. Establishment and biological characterization of canine histiocytic sarcoma cell lines. J. Vet. Med. Sci. 68: 1343-1346.
3. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
4. Banchereau, J., Ueno, H., Dhodapkar, M., Connolly, J., Finholt, J. P., Klechevsky, E., Blanck, J. P., Johnston, D. A., Palucka, A. K. and Fay, J. 2005. Immune and clinical outcomes in patients with stage IV melanoma vaccinated with peptide-pulsed dendritic cells derived from CD34+ progenitors and activated with type I interferon. J. Immunother. 28: 505-516.
5. Berntsen, A., Geertsen, P. F. and Svane, I. M. 2006. Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. Eur. Urol. 50: 34-43.
6. Cranmer, L. D., Trevor, K. T. and Hersh, E. M. 2004. Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol. Immunother. 53: 275-306.
7. Ferrara, A., Nonn, M., Sehr, P., Schreckenberger, C., Pawlita, M., Durst, M., Schneider, A. and Kaufmann, A. M. 2003. Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients. J. Cancer Res. Clin. Oncol. 129: 521-530.
8. Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G. and Levy, R. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2: 52-58.
9. Isotani, M., Katsuma, K., Tamura, K., Yamada, M., Yagihara, H., Azakami, D., Ono, K., Washizu, T. and Bonkobara, M. 2006. Efficient generation of canine bone marrow-derived dendritic cells. J. Vet. Med. Sci. 68: 809-814.
10. Koido, S., Kashiwaba, M., Chen, D., Gendler, S., Kufe, D. and Gong, J. 2000. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J. Immunol. 165: 5713-5719.
11. Lesterhuis, W. J., de Vries, I. J., Adema, G. J. and Punt, C. J. 2004. Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results. Ann. Oncol. 15 (Suppl. 4): 145-151.
12. Lodge, P. A., Jones, L. A., Bader, R. A., Murphy, G. P. and Salgaller, M. L. 2000. Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a phase II clinical trial. Cancer Res. 60: 829-833.
13. Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R. and Nestle, F. O. 2003. Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood 102: 2338-2344.
14. Marshall, J. 2003. Carcinoembryonic antigen-based vaccines. Semin. Oncol. 30 (Suppl. 8): 30-36.
15. Midgley, R. and Kerr, D. 1999. Colorectal cancer. Lancet 353: 391-399.
16. Millard, A. L., Ittelet, D., Schooneman, F. and Bernard, J. 2003. Dendritic cell KLH loading requirements for efficient CD4+ T-cell priming and help to peptide-specific cytotoxic T-cell response, in view of potential use in cancer vaccines. Vaccine 21: 869-876.
17. Morse, M. A., Deng, Y., Coleman, D., Hull, S., Kitrell-Fisher, E., Nair, S., Schlom, J., Ryback, M. E. and Lyerly, H. K. 1999. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen. Clin. Cancer Res. 5: 1331-1338.
18. Nakaichi, M., Taura, Y., Kanki, M., Mamba, K., Momoi, Y., Tsujimoto, H. and Nakama, S. 1996. Establishment and characterization of a new canine B-cell leukemia cell line. J. Vet. Med. Sci. 58: 469-471.
19. Slingluff, C. L. Jr., Petroni, G. R., Yamshchikov, G. V., Barnd, D. L., Eastham, S., Galavotti, H., Patterson, J. W., Deacon, D. H., Hibbitts, S., Teates, D., Neese, P. Y., Grosh, W. W., Chianese-Bullock, K. A., Woodson, E. M., Wiernasz, C. J., Merrill, P., Gibson, J., Ross, M. and Engelhard, V. H. 2003. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J. Clin. Oncol. 21: 4016-4026.
20. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
21. Tamura, K., Yamada, M., Isotani, M., Arai, H., Yagihara, H., Ono, K., Washizu, T. and Bonkobara, M. 2007. Induction of dendritic cell-mediated immune responses against canine malignant melanoma cells. Vet. J. (in press; doi:10.1016/j.tvjl.2006.11.005).
22. Timmerman, J. M., Czerwinski, D. K., Davis, T. A., Hsu, F. J., Benike, C., Hao, Z. M., Taidi, B., Rajapaksa, R., Caspar, C. B., Okada, C. Y., van Beckhoven, A., Liles, T. M., Engleman, E. G. and Levy, R. 2002. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients. Blood 99: 1517-1526.